# MRM Health NV

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mrm-health

- Industry: Biotechnology
- Headquarters: Gent, Belgium
- Website: www.mrmhealth.com
- Total disclosed funding: $29M
- Latest round: Series B (Sep 4, 2025)
- Investors on record: 11

## About

Founded in 2020 and based in Ghent, Belgium, MRM Health NV operates as a biotechnology company that uses SHIME, or simulator of the human intestinal microbial ecosystem technology, a platform to optimize, manage, and create human microbiome-based therapeutics to treat patients suffering from metabolic and inflammatory diseases.

## Funding rounds

- Series B, Sep 4, 2025, $14M — BNP Paribas Asset Management - Fund of funds, Ackermans & van Haaren, Merieux Equity Partners, VIB, Belgium Federal Holding Company, Qbic Fund, Athos Service, Biocodex
- Series B, May 7, 2020 — Korys, Merieux Equity Partners
- Series A, Feb 19, 2020, $15M — Ackermans & van Haaren, VIB, Qbic Fund, DuPont, ProDigest BVBA

## Investors

- Ackermans & van Haaren (https://capitalatlas.ai/funds/ackermans-van-haaren) — Series A, Series B
- VIB — Series A, Series B
- Qbic Fund (https://capitalatlas.ai/funds/qbic-fund) — Series A, Series B
- DuPont — Series A
- ProDigest BVBA — Series A
- Korys (https://capitalatlas.ai/funds/korys) — Series B
- Merieux Equity Partners (https://capitalatlas.ai/funds/merieux-equity-partners) — Series B
- BNP Paribas Asset Management - Fund of funds (https://capitalatlas.ai/funds/bnp-paribas-asset-management-fund-of-funds) — Series B
- Belgium Federal Holding Company — Series B
- Athos Service — Series B
- Biocodex — Series B